Search Within

Farhang Rabbani

Formats
  1. Journal Article (73)
  2. Meeting Abstract (10)
  3. Book Section (1)
Groups
  1. Surgery (58)
  2. Urology (56)
  3. Sloan Kettering Institute Faculty (29)
  4. Molecular Pharmacology and Chemistry Program Faculty (27)
  5. Population Sciences Research Program (10)
  6. Department of Medicine (9)

More Groups

People
  1. Peter Scardino (27)
  2. James Eastham (20)
  3. William Fair (13)
  4. John Mulhall (10)
  5. Karim Touijer (10)
  6. Paul Russo (10)

More People

Years
  1. 2013 (1)
  2. 2012 (1)
  3. 2011 (4)
  4. 2010 (9)
  5. 2009 (7)
  6. 2007 (6)

More Years

Publications
  1. Journal of Urology (20)
  2. BJU International (10)
  3. Journal of Clinical Oncology (9)
  4. Urology (8)
  5. Molecular Urology (7)
  6. Journal of Sexual Medicine (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (32)
  2. Wiley Blackwell (11)
  3. American Society of Clinical Oncology (9)
  4. Mary Ann Liebert, Inc (8)
  5. Elsevier Inc. (6)
  6. American Association for Cancer Research (3)

More Publishers

Results (84)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genotypic and phenotypic characterization of E2F1 in bladder cancer
    Meeting Abstract

    Rabbani, F.; Richon, V. M.; Lu, M.; Orlow, I.; Drobnjak, M.; Zhang, Z. F.; Cordon-Cardo, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • Open discussion following Dr. Goldberg's presentation
    Journal Article

    Rabbani, F.; Garnick, M. B.; Goldenberg, S. L.; Gleave, M.; Fourcroy, J.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Neither PSMA RT-PCR nor MTHFR genotype predicts PSA failure after prostatectomy
    Journal Article

    Kaplinsky, R. S.; Bacich, D. J.; O'Keefe, D. S.; Rabbani, F.; Tomassi, M. J.; Huryk, R.; Bastar, A. L.; Miller, W. H. Jr; Heston, W. D. W.; Fair, W. R.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Pathologic stage and biochemical recurrence after radical prostatectomy and neoadjuvant hormone therapy: Effect of treatment until PSA is undetectable
    Journal Article

    Fair, W. R.; Bastar, A.; Rabbani, F.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Nomograms to predict pathologic results of radical prostatectomy: Effect of neoadjuvant hormone therapy
    Journal Article

    Rabbani, F.; Dalbagni, G.; Bastar, A.; Fair, W. R.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Neoadjuvant hormone therapy before radical prostatectomy: Update on Phase II and III Memorial Sloan-Kettering Cancer Center trials
    Journal Article

    Rabbani, F.; Bastar, A.; Fair, W. R.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Neoadjuvant hormone therapy before radical prostatectomy: Update on Phase II and III Memorial Sloan-Kettering Cancer Center trials - Discussion
    Journal Article

    Pienta, K. J.; Roach, M.; Moul, J.; Rabbani, F.; Trachtenberg, J.; Goldenberg, L.; McLeod, D.
    Molecular Urology (1998)

    Fulltext@MSK | Save
  • Predictors of pathological stage before neoadjuvant androgen withdrawal therapy and radical prostatectomy
    Journal Article

    Rabbani, F.; Goldenberg, S. L.; Klotz, L. H.; The Canadian Urologic Oncology Group
    Journal of Urology (1998)

    Fulltext@MSK | Save
  • Site specific predictors of positive margins at radical prostatectomy: An argument for risk based modification of technique
    Journal Article

    Rabbani, F.; Bastar, A.; Fair, W. R.
    Journal of Urology (1998)

    Fulltext@MSK | Save
  • Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors
    Journal Article

    Perrotti, M.; Rabbani, F.; Russo, P.; Solomon, M. C.; Fair, W. R.
    Urology (1998)

    Fulltext@MSK | Save